委员会实施决定(EU) 2016/1190，依据欧洲议会和理事会条例(EC) No 258/97，授权反式白藜芦醇作为新奇成分上市(通报文件号C(2016) 4567)
技术法规类型：欧盟Eurlex法规 来源：tbtmap
EURLEX ID：32016D1190
OJ编号：OJ L 196, 21.7.2016, p. 53-55
中文标题：委员会实施决定(EU) 2016/1190，依据欧洲议会和理事会条例(EC) No 258/97，授权反式白藜芦醇作为新奇成分上市(通报文件号C(2016) 4567)
原文标题：Commission Implementing Decision (EU) 2016/1190 of 19 July 2016 authorising the placing on the market of trans-resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2016) 4567)
分类：13.30.14_食品
文件类型：二级立法 Decision|决定
生效日期：1001-01-01
废止日期：2058-12-31
法规全文：查看欧盟官方文件
| 21.7.2016 | EN | Official Journal of the European Union | L 196/53 |
COMMISSION IMPLEMENTING DECISION (EU) 2016/1190
of 19 July 2016
authorising the placing on the market of trans-resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
(notified under document C(2016) 4567)
(Only the English text is authentic)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (1), and in particular Article 7 thereof,
Whereas:
| (1) | On 8 November 2012, the company DSM Nutritional Products Ltd made a request to the competent authorities of Ireland to place trans-resveratrol on the market as a novel food ingredient within the meaning of point (f) of Article 1(2) of Regulation (EC) No 258/97. |
| (2) | On 28 June 2013, the competent food assessment body of Ireland issued its initial assessment report. In that report it came to the conclusion that trans-resveratrol meets the criteria for novel food ingredients set out in Article 3(1) of Regulation (EC) No 258/97. |
| (3) | On 4 September 2013, the Commission forwarded the initial assessment report to the other Member States. |
| (4) | Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97. |
| (5) | On 3 April 2014, the Commission consulted the European Food Safety Authority (EFSA) asking it to carry out an additional assessment for trans-resveratrol as novel food ingredient in accordance with Regulation (EC) No 258/97. |
| (6) | On 11 December 2015, EFSA concluded in its opinion on the safety of synthetic trans-resveratrol as a novel food (2), that trans-resveratrol used in food supplements intended for adults is safe under the proposed conditions of use. |
| (7) | That opinion gives sufficient grounds to establish that trans-resveratrol as a novel food ingredient complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97. |
| (8) | In its opinion, EFSA also indicated that trans-resveratrol may interact with specific medicines therefore, it is necessary to inform the consumers when consumed in combination with medicines. |
| (9) | Directive 2002/46/EC of the European Parliament and of the Council (3) lays down requirements for food supplements. The use of trans-resveratrol should be authorised without prejudice to that legislation. |
| (10) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
HAS ADOPTED THIS DECISION:
Article 1
Trans-resveratrol as specified in the Annex to this Decision may be placed on the market in the Union as a novel food ingredient to be used in food supplements in capsule or tablet form intended for adult population only with a maximum dose of 150 mg per day without prejudice to the provisions of Directive 2002/46/EC.
Article 2
1. The designation of trans-resveratrol authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘trans-resveratrol’.
2. The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.
Article 3
This Decision is addressed to DSM Nutritional Products Ltd, Heanor Gate Ind. Est. Heanor, Derbyshire, United Kingdom.
Done at Brussels, 19 July 2016.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission
(2) EFSA Journal 2016;14(1):4368.
(3) Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51).
ANNEX
SPECIFICATION OF TRANS-RESVERATROL
Definition:
| Chemical name | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
| Chemical formula | C14H12O3 |
| Molecular weight | 228,25 Da |
| CAS No | 501-36-0 |
Description: Trans-resveratrol is off-white to beige crystals.
Purity:
| Trans-resveratrol | Not less than 99 % |
| Total by-products (related substances) | Not more than 0,5 % |
| Any single related substance | Not more than 0,1 % |
| Lead | Not more than 1 ppm |
| Mercury | Not more than 0,1 ppm |
| Cadmium | Not more than 0,5 ppm |
| Arsenic | Not more than 1 ppm |
| Loss on drying | Not more than 0,5 % |
| Sulphated ash | Not more than 0,1 % |
| Diisopropylamine | Not more than 50 mg/kg |
附件:
托管标准，您可以接收以下服务：
1 标准定期系统查新,若有最新版本,会以站内短信或邮件的形式通知用户；
2 随时在标准托管页面中查看到该条标准的最新状态；
3 若用户有在学习和科研中的需要，可以在标准托管页面中试阅标准；
4 企业如果需要上新产品,我院及时提供标准查询、采购等方面的支持；
5 为企业在标准制修订、企业良好行为创建以及标准化试点过程中遇到的困难,可联系我院指定相关专家负责进行指导帮助、提供政策咨询；
6 为企业提供标准化政策的解读、标准化知识的推广培训、标准自我公开声明、标准文献的免费查询、企业标准化体系建设等方面的标准化服务；
标准资讯点击排行榜 全部
资讯标题点击
[[ n.title ]] [[ n.read ]]大连标准化公共服务平台
版权：大连标准化研究院有限公司
地址：大连市中山区高原街56号
电话：0411-82740851
